Tumor-infiltrating lymphocyte treatment for anti-PD-1-resistant metastatic lung cancer: a phase 1 trial
Ben Creelan, Chao Wang, Jamie K. Teer, Eric M. Toloza, Jiqiang Yao, Sungjune Kim, Ana Marie Landin, John E. Mullinax, James J. Saller, Andreas Saltos, David Noyes, Leighann B. Montoya, Wesley Curry, Shari Pilon‐Thomas, Alberto Chiappori, Tawee Tanvetyanon, Frederic J. Kaye, Zachary Thompson, Sean Yoder, Bin Fang, John M. Koomen, Amod A. Sarnaik, Dung‐Tsa Chen, José R. Conejo-García, Eric B. Haura, Scott Antonia
Topics & Concepts
MedicineNivolumabLung cancerTumor-infiltrating lymphocytesOncologyInternal medicineCancerFludarabineCyclophosphamideImmunotherapyImmunologyChemotherapyCAR-T cell therapy researchImmunotherapy and Immune ResponsesCancer Immunotherapy and Biomarkers